Contact Us
|
Client Login
PRODUCTS & SERVICES
Antibody Products
Antibody Products Store
Neuroscience
Epitope Tags
Structural Proteins & Cell Components
Signal Transduction
Immunopathology
Detection Chemistries & Ancillaries
Custom Immunology Services
Clinical Services
Bioanalytical
Central Laboratory
Clinical Development (Phase I-III)
Discovery & Translational Services
Antibody Products
Biomarker Center of Excellence
BioPathways
Computational Biology
Discovery
Genomics Laboratory
Immunology
Vaccines & Infectious Disease
Nonclinical Services
Antibody Products
Bioanalytical Services
Discovery
Drug Metabolism & Pharmacokinetics
Immunology
Radiosynthesis
Research Models
Safety Pharmacology
Toxicology
Vaccines & Infectious Disease
Biopharmaceutical CMC Solutions
Biorepository Services
Environmental Sciences
Genomics Laboratory
Integration in Drug Development
Market Access
Nutritional Chemistry & Food Safety
Secure Data Access
Strategic Partnering
CAREERS
Search Jobs
College / University
Featured Jobs
Diversity
Benefits
现在就加入科文斯
STUDY PARTICIPANTS
INVESTORS
Investor Information
Investor Home
Stock Information
Board of Directors
Corporate Governance Guidelines
Analyst Coverage
Investor FAQ
Presentations & Webcasts
Financial Information
SEC Filings
Annual Reports
Press Releases
Calendar of Events
Request Information
NEWS
Press Releases
Media Relations
ABOUT COVANCE
Company Overview
Global Locations
Corporate Responsibility
Business Integrity Program
Animal Welfare
Covance.Asia
RESOURCE CENTER
Blog
Investors
Investor Information
Financial Information
SEC Filings
Annual Reports
Press Releases
Calendar of Events
Request Information
Home
> Investors >
Financial Information
>
Press Releases
Financial Information
Press Releases
2004
|
2005
|
2006
|
2007
|
2008
|
2009
|
2010
|
2011
|
2012
|
2013
Date
Title
19-Dec-2005
Joseph L. Herring to Become Chairman of Covance Inc.
Print
19-Dec-2005
Covance Announces Plan to Repatriate Accumulated Foreign Earnings Under the Provisions of the American Jobs Creation Act
Print
14-Dec-2005
Covance Strengthens Drug Risk Minimization Services Team Leadership
Print
29-Nov-2005
Covance Continues Enhancement of Lablink Web Monitoring Tool for Clinical Trial Laboratory Tests
Print
21-Nov-2005
Covance Named Mortara Certified Partner For ECG Compliance With FDA's New Digital Standard
Print
24-Oct-2005
New NDLEA Testing Method Goes On-line at Covance
Print
24-Oct-2005
Covance Increases Stability Chamber Capacity
Print
19-Oct-2005
Covance Grows EPS 26%; Delivers Record Orders And Margins
Print
15-Sep-2005
Covance Study Highlights Continued Need For Off-Label Drug Use In Oncology Practice
Print
23-Aug-2005
Covance Increases Its Phase I Clinical Capacity With Acquisition Of GFI Research Center
Print
20-Jul-2005
Covance Reports Strong Earnings Growth Of 28% To $0.46 Per Share
Print
18-Jul-2005
Covance Supports Chinese Regional Laboratory In Achieving Level 1 NGSP Certification
Print
07-Jul-2005
Covance Laboratories Continues Expansion Of Biotechnology Services Group
Print
27-Jun-2005
Covance Acquires Antibodies Product Line Of Sternberger Monoclonals
Print
06-Jun-2005
Covance Files Lawsuit Against PETA And Its Infiltrator
Print
20-Apr-2005
Covance Reports EPS Growth Of 32.4% To $0.45
Print
23-Mar-2005
Covance and Expression Analysis Team to Provide Genomic Microarray Testing Services for Clinical Trials
Print
21-Feb-2005
Covance Clinical Research Unit in Leeds Opens New GMP Pharmacy
Print
26-Jan-2005
Covance Grows 2004 EPS 26% To $1.52/Share
Print
17-Jan-2005
Covance Expands Capabilities Of Lablink Web Monitoring Tool For Clinical Trial Laboratory Tests
Print
Home
|
Animal Welfare
|
Privacy Policy
|
Contact Us
|
Site Map
|
Investigators
|
Covance.Asia
RSS
© Copyright 2013 Covance Inc. All rights reserved.